Investigating underlying human immunity genes, implicated diseases and their relationship to COVID-19

Genomic analysis of bovine respiratory disease resistance in preweaned dairy calves diagnosed by a combination of clinical signs and thoracic ultrasonography

Bovine respiratory disease (BRD) poses a significant risk of morbidity and mortality in preweaned dairy calves. Research indicates that this multifactorial disorder can be attributed to the involvement of various pathogens. Currently, there is little information from genome-wide association studies (GWAS) for BRD resistance in young calves based on objective measures and classification of the disease. In this study, we moved forward in phenotyping BRD by coupling two diagnostic tests, the thoracic ultrasonography (TUS) and Wisconsin respiratory score (WISC), in order to assess susceptible and resistant animals to BRD. A total of 240 individuals were scored for BRD using TUS and WISC. A GWAS was performed using a selective genotyping approach to identify Quantitative Trait Loci (QTL) for BRD resistance. A total of 47 calves classified as BRD resistant (TUS ≤  1/ WISC ≤  4) and 47 as BRD susceptible (TUS =  5/ any WISC) were genotyped with the NEOGEN's GGP Bovine 100K SNP chip. QTL were then identified comparing the SNPs allelic frequencies between the two groups. A total of 28 QTL regions (QTLRs) were defined according to significative SNPs, 141 genes were annotated in the defined QTLRs. The genes were functionally classified into 4 main categories, i.e., i) regulation of systemic arterial blood pressure, ii) fertility, iii) immune function, and iv) filament cytoskeleton. Furthermore, 61 out of 141 genes identified here can be considered promising candidate genes since they were already associated with BRD resistance in published GWAS studies in dairy cattle. The ASB9, BMX, EPSTI1, and OLFM4 genes were identified in 4 of the 6 considered studies. This study paves the way for further research to mine the genome for resistance to respiratory diseases, utilizing an accurate classification process.

Mapping genomic regions affecting sensitivity to bovine respiratory disease on chromosome X using selective DNA pooling

Bovine respiratory disease is a leading health problem in feedlot cattle. Identification of affecting genes is essential for selection for decrease sensitivity. Chromosome X is a special attractive target for gene mapping in light of reports on both sexual dimorphism in immunity and higher susceptibility of males to this disease. However, diagnosis is challenging and clinical signs often go undetected. Kosher scoring of lung adhesions was used as a cost-effective proxy diagnosis. Selective DNA pooling was applied for cost-effective mapping of regions associated with sensitivity to the disease on chromosome X in Israeli Holstein male calves. A total of 9 regions were found, more than twice of any of the autosomes. All regions overlapped or were very close to previously reported regions. Bioinformatics survey found candidate-by-location genes in these regions. Functional analyses identified candidates-by-function among these genes. Network analyses connected the genes and found possible relations of the genes and the networks with morbidity, and specifically with sensitivity to bovine respiratory disease. The relatively large number of affecting regions and the candidate genes on the sex chromosome may explain part of the higher susceptibility of males and provide genomic and management targets for mitigating this disease.

The SLC6A15-SLC6A20 Neutral Amino Acid Transporter Subfamily: Functions, Diseases, and Their Therapeutic Relevance

The neutral amino acid transporter subfamily that consists of six members, consecutively SLC6A15-SLC620, also called orphan transporters, represents membrane, sodium-dependent symporter proteins that belong to the family of solute carrier 6 (SLC6). Primarily, they mediate the transport of neutral amino acids from the extracellular milieu toward cell or storage vesicles utilizing an electric membrane potential as the driving force. Orphan transporters are widely distributed throughout the body, covering many systems; for instance, the central nervous, renal, or intestinal system, supplying cells into molecules used in biochemical, signaling, and building pathways afterward. They are responsible for intestinal absorption and renal reabsorption of amino acids. In the central nervous system, orphan transporters constitute a significant medium for the provision of neurotransmitter precursors. Diseases related with aforementioned transporters highlight their significance; SLC6A19 mutations are associated with metabolic Hartnup disorder, whereas altered expression of SLC6A15 has been associated with a depression/stress-related disorders. Mutations of SLC6A18-SLCA20 cause iminoglycinuria and/or hyperglycinuria. SLC6A18-SLC6A20 to reach the cellular membrane require an ancillary unit ACE2 that is a molecular target for the spike protein of the SARS-CoV-2 virus. SLC6A19 has been proposed as a molecular target for the treatment of metabolic disorders resembling gastric surgery bypass. Inhibition of SLC6A15 appears to have a promising outcome in the treatment of psychiatric disorders. SLC6A19 and SLC6A20 have been suggested as potential targets in the treatment of COVID-19. In this review, we gathered recent advances on orphan transporters, their structure, functions, related disorders, and diseases, and in particular their relevance as therapeutic targets. SIGNIFICANCE STATEMENT: The following review systematizes current knowledge about the SLC6A15-SLCA20 neutral amino acid transporter subfamily and their therapeutic relevance in the treatment of different diseases.